New Zealand markets closed

Candel Therapeutics, Inc. (CADL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.55+0.75 (+9.62%)
At close: 04:00PM EDT
8.70 +0.15 (+1.75%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
125
125
125
-
Operating expenses
Research development
23,139
24,506
20,787
15,178
8,754
-
Selling general and administrative
13,521
13,885
14,060
10,673
5,181
-
Total operating expenses
36,672
38,391
34,799
24,775
13,311
-
Operating income or loss
-36,672
-38,391
-34,674
-24,650
-13,186
-
Interest expense
2,632
2,595
1,708
53
-
-
Total other income/expenses net
249
966
16,370
-11,421
-4,605
-
Income before tax
-37,365
-37,939
-18,794
-36,124
-17,680
-
Income from continuing operations
-37,365
-37,939
-18,794
-36,124
-17,680
-
Net income
-37,365
-37,939
-18,794
-36,124
-17,680
-
Net income available to common shareholders
-37,365
-37,939
-18,794
-36,124
-17,680
-
Basic EPS
-1.10
-
-0.65
-1.91
-0.94
-0.44
Diluted EPS
-1.10
-
-0.65
-1.91
-0.94
-0.44
Basic average shares
28,915
-
28,823
18,873
18,714
18,682
Diluted average shares
28,915
-
28,823
18,873
18,714
18,682